Agreement signedPublished 2 Feb 2026

Lilly /
Ventyx

Lilly to acquire Ventyx in cash merger

Buy side: Lilly
Buy sideLilly
Target: Ventyx
TargetVentyx
Ventyx Biosciences, Inc. · 2 Feb 2026Source
Buy side: Lilly
Buy sideLilly
Target: Ventyx
TargetVentyx
01 / BuyerLilly
02 / TargetVentyx
Source for the buyer and target: Ventyx Biosciences, Inc.

For the buyer and target.

“On January 7, 2026, we announced our entry into the merger agreement, which provides that Lilly will acquire Ventyx for approximately $1.2 billion in cash.”

Published 2 Feb 2026

Open the source
01

What happened

Ventyx announced that it entered into a merger agreement under which Lilly will acquire Ventyx for approximately $1.2 billion in cash. The merger requires approval by Ventyx stockholders. [01]

02

The source

Everything on this page comes from the source below, quoted word for word.

01
Source · Ventyx Biosciences, Inc.

Lilly to acquire Ventyx in cash merger

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Ventyx Biosciences, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.